Ftse Mib
34.339,32
0,00%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.912,65
-0,22%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Cyprotex (CRX) Cyprotex (CRX) Notizie

CRX

Cyprotex (CRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:CRX
DataOraFonteTitoloSimboloCompagnia
15/12/201608:00UK RegulatoryAIM Cancellation - Cyprotex PlcLSE:CRXCyprotex
14/12/201617:03UK RegulatoryCyprotex PLC Scheme of Arrangement becomes effectiveLSE:CRXCyprotex
14/12/201608:30UK RegulatoryAIM Suspension - Cyprotex PlcLSE:CRXCyprotex
13/12/201616:32UK RegulatoryCyprotex PLC Director DealingLSE:CRXCyprotex
13/12/201612:46UK RegulatoryCyprotex PLC Court Sanction of Scheme of ArrangementLSE:CRXCyprotex
09/12/201610:38UK RegulatoryNplus1 Singer Capital Markets Ltd Form 8.5 (EPT/RI) Cyprotex PlcLSE:CRXCyprotex
07/12/201611:02UK RegulatoryNplus1 Singer Capital Markets Ltd Form 8.5 (EPT/RI) Cyprotex plcLSE:CRXCyprotex
06/12/201610:04UK RegulatoryNplus1 Singer Capital Markets Ltd Form 8.5 (EPT/RI) - Cyprotex PLCLSE:CRXCyprotex
05/12/201619:34UK RegulatoryLinda Freeman Form 8.3 - Cyprotex PLCLSE:CRXCyprotex
05/12/201619:34UK RegulatoryLinda Freeman Form 8.3 - Cyprotex PlcLSE:CRXCyprotex
05/12/201610:12UK RegulatoryODDO Meriten Asset Management Form 8.3 - Cyprotex PLCLSE:CRXCyprotex
01/12/201614:40UK RegulatoryCyprotex PLC Results of Court Meeting & General MeetingLSE:CRXCyprotex
29/11/201611:31UK RegulatoryODDO Meriten Asset Management Form 8.3 - CYPROTEX PLCLSE:CRXCyprotex
29/11/201611:28Alliance NewsAlliance NewsCyprotex Launches Third Skin Sensitisation Potential In Vitro TestLSE:CRXCyprotex
29/11/201608:01RNS Non-RegulatoryCyprotex PLC Launch of in vitro h-CLAT ServiceLSE:CRXCyprotex
04/11/201608:00UK RegulatoryCyprotex PLC Posting of Scheme DocumentLSE:CRXCyprotex
01/11/201610:09UK RegulatoryNplus1 Singer Capital Markets Ltd Form 8.5 (EPT/RI) CyprotexLSE:CRXCyprotex
27/10/201613:39UK RegulatoryNplus1 Singer Capital Markets Ltd Form 8.5 (EPT/RI) CYPROTEX PLCLSE:CRXCyprotex
27/10/201611:11UK RegulatoryRichard Sneller Form 8.3 - Cyprotex Plc - AmendmentLSE:CRXCyprotex
27/10/201611:11PR Newswire (US)RICHARD SNELLER - Form 8.3 - Cyprotex Plc - AmendmentLSE:CRXCyprotex
26/10/201608:59Alliance NewsAlliance NewsCyprotex Agrees To GBP41.7 Million Takeover By Germany's EvotecLSE:CRXCyprotex
26/10/201608:00UK RegulatoryCyprotex PLC Rule 2.7 Announcement: Recommended OfferLSE:CRXCyprotex
21/10/201616:31UK RegulatoryCyprotex PLC Director DeclarationLSE:CRXCyprotex
20/10/201609:57UK RegulatoryNplus1 Singer Capital Markets Ltd Form 8.5 (EPT/RI) - Cyprotex PlcLSE:CRXCyprotex
13/10/201608:00UK RegulatoryCyprotex PLC Cyprotex PLC - Rule 2.9 AnnouncementLSE:CRXCyprotex
06/10/201618:22Alliance NewsAlliance NewsCyprotex Issues 40,702 Shares After Loan Notes Converted (ALLISS)LSE:CRXCyprotex
06/10/201618:15UK RegulatoryCyprotex PLC Conversion of Loan Notes & TVRLSE:CRXCyprotex
06/10/201608:00RNS Non-RegulatoryCyprotex PLC New DDI-FusionLSE:CRXCyprotex
26/09/201611:02UK RegulatoryCharles Stanley & Co. Ltd. Form 8.3 - Cyprotex PlcLSE:CRXCyprotex
26/09/201608:01RNS Non-RegulatoryCyprotex PLC Appointment of new Director of US OperationsLSE:CRXCyprotex
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:CRX

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network